CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-26 | NARACHI MICHAEL Director | Grant or award | +2,550 | 12,300 | ||
| 2020-06-26 | NARACHI MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +4,250 | 4,250 | ||
| 2020-06-26 | Fust Matthew K Director | Grant or award | +2,550 | 13,550 | ||
| 2020-06-26 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +4,250 | 4,250 | ||
| 2020-06-26 | Ekman Lars Director | Grant or award | +2,550 | 12,300 | ||
| 2020-06-26 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +4,250 | 4,250 | ||
| 2020-06-26 | Dunsire Deborah Director | Grant or award | +2,550 | 10,425 | ||
| 2020-06-26 | Dunsire Deborah Director | Grant or award · Stock Option (Right to Buy) | +4,250 | 4,250 | ||
| 2020-06-26 | Aliski William Director | Grant or award | +2,550 | 57,018 | ||
| 2020-06-26 | Aliski William Director | Grant or award · Stock Option (Right to Buy) | +4,250 | 4,250 | ||
| 2020-06-20 | Parschauer Karah Herdman EVP and General Counsel | Shares withheld for taxes | −649 | $78.22 | $51K | 26,663 |
| 2020-06-19 | Harris Erik EVP & Chief Commercial Officer | Shares withheld for taxes | −303 | $78.22 | $24K | 23,850 |
| 2020-06-04 | Sharp Shalini CFO & Executive Vice President | Exercise or conversion | +2,564 | $48.43 | $124K | 103,772 |
| 2020-06-04 | Sharp Shalini CFO & Executive Vice President | Sale | −2,564 | $74.01 | $190K | 101,208 |
| 2020-06-04 | Sharp Shalini CFO & Executive Vice President | Exercise or conversion · Stock Option (Right to Buy) | −2,564 | 18,981 | ||
| 2020-06-03 | Harris Erik EVP & Chief Commercial Officer | Sale | −2,516 | $74.69 | $188K | 20,854 |
| 2020-06-03 | Sharp Shalini CFO & Executive Vice President | Exercise or conversion | +10,234 | $48.43 | $496K | 111,442 |
| 2020-06-03 | Sharp Shalini CFO & Executive Vice President | Sale | −10,234 | $74.23 | $760K | 101,208 |
| 2020-06-03 | Sharp Shalini CFO & Executive Vice President | Exercise or conversion · Stock Option (Right to Buy) | −10,234 | 21,545 | ||
| 2020-06-01 | Huang Dennis Karl EVP & Chief Tech Ops Officer | Shares withheld for taxes | −262 | $69.38 | $18K | 34,961 |
Page 27 of 32 · 632 trades